WCG
CVS icon

Weaver Consulting Group’s CVS Health CVS Stock Holding History

Weaver Consulting Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,917
Closed -$388K – 202
2023
Q4 		$388K Buy
4,917
+30
+0.6% +$2.13K 0.16% 115
2023
Q3 		$341K Buy
4,887
+10
+0.2% +$709 0.15% 119
2023
Q2 		$337K Sell
4,877
-122
-2% -$8.68K 0.15% 123
2023
Q1 		$371K Buy
4,999
+100
+2% +$8.39K 0.17% 113
2022
Q4 		$457K Buy
4,899
+542
+12% +$52.3K 0.23% 81
2022
Q3 		$416K Buy
4,357
+795
+22% +$78.7K 0.24% 84
2022
Q2 		$330K Sell
3,562
-100
-3% -$9.76K 0.18% 109
2022
Q1 		$371K Sell
3,662
-28
-0.8% -$2.94K 0.18% 110
2021
Q4 		$381K Buy
3,690
+78
+2% +$7.21K 0.18% 103
2021
Q3 		$307K Sell
3,612
-236
-6% -$19.8K 0.17% 113
2021
Q2 		$321K Buy
3,848
+251
+7% +$20.6K 0.18% 107
2021
Q1 		$271K Buy
+3,597
New +$262K 0.17% 107
2020
Q4 		– Sell
-1,947
Closed -$114K – 299
2020
Q3 		$114K Buy
1,947
+200
+11% +$12.4K 0.07% 175
2020
Q2 		$114K Buy
1,747
+139
+9% +$8.75K 0.07% 173
2020
Q1 		$95K Buy
1,608
+17
+1% +$1.14K 0.06% 162
2019
Q4 		$100K Buy
1,591
+84
+6% +$5.9K 0.05% 170
2019
Q3 		$85K Hold
1,507
– – 0.05% 175
2019
Q2 		$82K Hold
1,507
– – 0.04% 169
2019
Q1 		$83K Buy
+1,507
New +$93K 0.02% 361

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Weaver Consulting Group's CVS Position: Q1 2024 in Review

Weaver Consulting Group sold out of CVS Health (CVS) in Q1 2024, closing a stake of 4,917 shares — an estimated $388K sold.

Weaver Consulting Group first reported a position in CVS in Q1 2019 and held it in 19 quarters. The position peaked at $457K in Q4 2022. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Weaver Consulting Group reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Weaver Consulting Group sold 4,917 CVS Health shares in Q1 2024, an estimated $388K.
  • Weaver Consulting Group first reported a position in CVS Health in Q1 2019 and held it in 19 quarters.
  • Weaver Consulting Group's CVS Health position peaked at $457K in Q4 2022.
  • 2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Weaver Consulting Group's 13F filing for Q1 2024, filed 16 Apr 2024.